FDA Approves SOMAŽ (carisoprodol) 250 mg Product in the US
- [September, 2007]
Meda acquires exclusive rights to potential specialty blockbuster product in the US
- [September, 2007]
Strategic Acquisition of MedPointe Inc completed
- [August, 2007]
Meda enters the US market through the strategic acquisition of MedPointe Inc
- [July, 2007]
MedPointe Pharmaceuticals Announces the Appointment of John J.Howarth to Vice President of Public Affairs and Investor Relations
- [May, 2007]
MedPointe Settles Litigation with Hi-Tech and Successfully Enforces Patent Covering Its Tussi-12® D Products
- [May, 2007]
Further inquiries should be directed to info@medapharma.us
|